Programme Overview
Day 1 | Day 2 | Day 3 | Symposium
0700 - 1800 hrs Registration - April 3, Friday
Day 1 - Friday, April 3, 2009
0830 - 0900 hrs Opening Address by VIP/Chairs of AOS & Ceremony
0900 - 1020 hrs Opening Lectures
Moderators: David COLLINGRIGDE, UK; SOO Khee Chee, Singapore
0900 - 0935 hrs Opening Lecture 1 - The Breast Health Global Initiative:
Guideline Implementation in Low and Middle Income Countries (LMCs)
- Benjamin ANDERSON, USA
0935 - 1010 hrs Opening Lecture 2 - Infectious Causes of Human Cancers - Novel Developments
- Harald zur HAUSEN, Germany
1010 - 1020 hrs Questions and Answers
1020 - 1040 hrs Tea Break
1040 - 1240 hrs Lung Cancer Lectures
Moderator: LIAO Meilin, China
1040 - 1115 hrs Proposed new staging system for NSCLC – Implications for the clinician
- Peter GOLDSTRAW, UK
1115 - 1150 hrs Optimal management of locally advanced N2 NSCLC
- Julie BRAHMER, USA
1150 - 1225 hrs The role of adjuvant chemotherapy in NSCLC
- Mark VINCENT, Canada
1225 - 1235 hrs Questions and Answers
1240 - 1340 hrs GSK Lunch Symposium (Gallery East, Level 3)
Anti-ErbB2 therapy: Old and new
- Jenny CHANG, USA
1345 - 1545 hrs Breast Cancer Lectures (Theatre)
Moderator: WONG Nan Soon, Singapore, JP JULKA, India
1345 - 1420 hrs Advances in adjuvant chemotherapy for early breast cancer: better regimens or better patient selection?
- LU Yen-Shen, Taiwan
1420 - 1455 hrs Optimizing adjuvant endocrine therapy for early breast cancer in premenopausal women
- Kathleen PRITCHARD, Canada
1455 - 1510 hrs Questions and Answers
1510 - 1530 hrs Tea Break
1530 -1730 hrs Haemato-Oncology Lectures (Theatre)
Moderator: ONG Sin Tiong, Singapore
1530 - 1605 hrs Lymphomas associated with immunodeficiency
- Alexandra LEVINE, USA
1605 - 1640 hrs Optimizing the management of Hodgkin's Lymphoma
- Ranjana ADVANI, USA
1640 - 1715 hrs Major advances in haematologic malignancies – ASCO/ASH updates: 2008–2009
- Alexandra LEVINE, USA
1715 - 1730 hrs Questions & Answers
1730 - 1900 hrs SEAMOF (Ballroom 1, Level 2)
Southeast Asia exchange training programme
- country updates on medical oncologists training and needs
Chair: LEE Soo Chin, Singapore
1900 – 2030 hrs Pfizer Dinner Symposium (Ballroom 1, Level 2)
Updates in endocrine and targeted therapies in the management of breast cancer
Chair: WONG Nan Soon, Singapore
Speaker: Kathleen PRITCHARD, Canada
Speaker: LEE Soo Chin, Singapore
SEAMOF – con’t (Ballroom 1, Level 2)
Chair: TAN Yew Oo, Singapore
2030 – 2045 hrs Developing multidisciplinary care in Southeast Asia: Opportunities and challenges
2045 – 2100 hrs Enhancing cooperation in providing oncology care in Southeast Asia
End of Day 1

**Programme is correct as of 28 March 2009 and is subjected to changes.
Copyright © 2008 Elsevier (Singapore) Pte Ltd.